Back | Next |
home / stock / imuc / imuc message board
Subject | By | Source | When |
---|---|---|---|
$5.00 still too low. | Benwahsauce | investorshub | 09/22/2022 12:53:36 PM |
Im looking for $5.00 here sooner than later. | OTC_Hussler | investorshub | 09/22/2022 9:25:44 AM |
$1 is much too low. This stock could | Benwahsauce | investorshub | 09/21/2022 8:45:46 PM |
Nice buys today. Hoping to be over a | Lowhndcpr | investorshub | 09/21/2022 6:48:46 PM |
Raised $750k with convertible note. https://www.sec.gov/Archives/edgar/data/8224 | OTC_Hussler | investorshub | 09/12/2022 8:41:05 PM |
Were going to laugh all the way to | OTC_Hussler | investorshub | 08/01/2022 3:46:51 PM |
Nice to see myself in the green here | Lowhndcpr | investorshub | 07/29/2022 8:01:17 PM |
Confirmed yet? | OTC_Hussler | investorshub | 07/28/2022 10:52:25 PM |
We shall discuss later when confirmed. There can be | Benwahsauce | investorshub | 07/23/2022 3:37:04 AM |
Something derogatory or Continuous Net Settlement. | OTC_Hussler | investorshub | 07/22/2022 1:13:46 AM |
The real question is.what do you think it means??? | Benwahsauce | investorshub | 07/21/2022 8:41:00 PM |
Educate me on the meaning of CNS and | OTC_Hussler | investorshub | 07/21/2022 6:40:06 PM |
Finally all CNS funneled out! Go time is near | Benwahsauce | investorshub | 07/21/2022 4:44:06 PM |
funnel out the CNS's | Golf4Food | investorshub | 07/21/2022 3:33:08 PM |
Yes Sir! I's waiting! | OTC_Hussler | investorshub | 07/11/2022 2:45:13 PM |
I find it funny that last 6 months | Benwahsauce | investorshub | 07/07/2022 5:04:53 PM |
No shares below. This is really good | Benwahsauce | investorshub | 07/05/2022 2:46:02 PM |
Are they stop loss hunting today? | OTC_Hussler | investorshub | 06/30/2022 7:28:50 PM |
You never know! | Benwahsauce | investorshub | 06/30/2022 2:04:31 PM |
I'm hoping so! | OTC_Hussler | investorshub | 06/30/2022 1:14:46 PM |
News, Short Squeeze, Breakout and More Instantly...
ImmunoCellular Therapeutics Ltd. Company Name:
IMUC Stock Symbol:
OTCMKTS Market:
EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613 PR Newswire MONTVALE, N.J. , Nov. 7, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug...
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil PR Newswire Results indicate that EOM613 treatment mitigates cytokine release in patients with COVID-19 pulmonary vascular inflammation MONTVALE, N.J. , ...
REDWOOD CITY, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment of Rahul Singhvi, Sc.D., to its Board of Directors. Dr. Singhvi is a biotechnology indu...